J&J further widens Tylenol recall; DEA shuts down pain drug maker;

> J&J has for the second time expanded its Tylenol recall--now including Benadryl Allergy Ultratablets and Extra Strength Tylenol--saying the medications were mistakenly left out of the original recall. Report

> The U.S. Drug Enforcement Administration has suspended the license of Harvard Drug Group, alleging that it sold 12 million doses of prescription painkillers to distributors that sold the drugs for illegitimate purposes. Article

> Eisai Machinery and Crest Solutions have launched PharmaMarker, a track and trace packaging system for pharmaceutical products. Item

> CSafe, maker of the AcuTemp RKN active temperature controlled cargo container, and pharma cargo service provider Cathay Pacific, have signed a master lease agreement for CSafe containers. Release

> SGS Consumer Testing has expanded its package testing services to include pharmaceutical products and medical devices . Release

> Novavax has named John Madsen head of process and manufacturing operations and Steven Pincus as head of analytical and quality ops. Release

> ATMI has unveiled single-use bioprocess vessels in 2-D and 3-D bag formats for the storage and transfer of sterile liquids; volumes reach 3,000 liters. Release

> India's biopharma companies complain that regulators need to keep pace with technology to speed drug approval processes. Article

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.